Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients?

Pow EH, Kwong DL, Sham JS, Lee VH, Ng SC.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e213-21. doi: 10.1016/j.ijrobp.2011.12.040. Epub 2012 Mar 2.

PMID:
22386514
2.

Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.

Parliament MB, Scrimger RA, Anderson SG, Kurien EC, Thompson HK, Field GC, Hanson J.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):663-73.

PMID:
14967418
3.

Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study.

McMillan AS, Pow EH, Kwong DL, Wong MC, Sham JS, Leung LH, Leung WK.

Head Neck. 2006 Aug;28(8):712-22.

PMID:
16475203
4.

A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.

Strigari L, Benassi M, Arcangeli G, Bruzzaniti V, Giovinazzo G, Marucci L.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):269-76. doi: 10.1016/j.ijrobp.2009.07.1734. Epub 2010 Jan 25.

PMID:
20100642
5.
6.

Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.

Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):61-70.

PMID:
12909216
7.

Parotid gland sparing with helical tomotherapy in head-and-neck cancer.

Voordeckers M, Farrag A, Everaert H, Tournel K, Storme G, Verellen D, De Ridder M.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):443-8. doi: 10.1016/j.ijrobp.2011.11.070. Epub 2012 Jul 25.

PMID:
22836056
8.

A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, Low DA.

Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):907-16.

PMID:
11240231
9.

Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.

Kwong DL, Pow EH, Sham JS, McMillan AS, Leung LH, Leung WK, Chua DT, Cheng AC, Wu PM, Au GK.

Cancer. 2004 Oct 1;101(7):1584-93.

10.

Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.

Wang ZH, Yan C, Zhang ZY, Zhang CP, Hu HS, Tu WY, Kirwan J, Mendenhall WM.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1479-87. doi: 10.1016/j.ijrobp.2010.07.1990. Epub 2010 Oct 8.

PMID:
20934262
11.

Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.

Fang FM, Chien CY, Tsai WL, Chen HC, Hsu HC, Lui CC, Huang TL, Huang HY.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):356-64. doi: 10.1016/j.ijrobp.2007.12.054. Epub 2008 Mar 20.

PMID:
18355980
12.
13.

Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy.

Kodaira T, Tomita N, Tachibana H, Nakamura T, Nakahara R, Inokuchi H, Fuwa N.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1129-34. doi: 10.1016/j.ijrobp.2008.06.1936. Epub 2008 Oct 14.

PMID:
18922651
14.

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.

Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M, Maingon P, Giraud P, Bourhis J, Marchesi V, M├Ęge A, Peiffert D.

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1309-17. Epub 2007 Feb 7.

PMID:
17289292
15.
16.

Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.

Lips I, Dehnad H, Kruger AB, van Moorselaar J, van der Heide U, Battermann J, van Vulpen M.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):656-61. Epub 2007 May 23.

PMID:
17512127
17.

Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.

Marzi S, Iaccarino G, Pasciuti K, Soriani A, Benassi M, Arcangeli G, Giovinazzo G, Benassi M, Marucci L.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1252-9. doi: 10.1016/j.ijrobp.2008.11.020.

PMID:
19251097
18.

Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.

Scrimger R, Kanji A, Parliament M, Warkentin H, Field C, Jha N, Hanson J.

Am J Clin Oncol. 2007 Jun;30(3):271-7.

PMID:
17551304
19.
20.

Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.

Yang H, Hu W, Wang W, Chen P, Ding W, Luo W.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e47-54. doi: 10.1016/j.ijrobp.2012.09.033. Epub 2012 Nov 1.

PMID:
23122981
Items per page

Supplemental Content

Write to the Help Desk